FDA completes first-cycle review of NRx ketamine ANDA with packaging query
Go back to FDA completes first-cycle review of NRx ketamine ANDA with packaging query| (NASDAQ: NRXP) | Delayed: 3.34 +0.02 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.32 | 52 Week High | $ | |||
| Open | $3.37 | 52 Week Low | $ | |||
| Day High | $3.39 | P/E | N/A | |||
| Day Low | $3.31 | EPS | $ | |||
| Volume | 101,790 | |||||
